Structural Failures Halt Pfizer HQ Office-to-Residential Conversion in Midtown

A major office-to-residential conversion project in Midtown Manhattan has been halted following the discovery of serious structural deficiencies, according to The Real Deal. Mayor Zohran Mamdani characterized the situation at 235 East 42nd Street — the former Pfizer headquarters — as “extremely dangerous” on Tuesday morning after reports emerged of falling bricks and compromised structural elements at the site.

The FDNY responded before 8 a.m., and inspectors found multiple sagging floors on the building’s upper levels along with two buckling support columns. Construction workers were evacuated from the site, which is being developed by David Werner and Nathan Berman’s Metro Loft Management. Gensler is serving as the project architect. The conversion is among the largest office-to-residential projects currently underway in New York City.

ParkPoint Perspective

This incident underscores the execution risk embedded in large-scale adaptive reuse, particularly in aging commercial stock where structural conditions may diverge significantly from pre-acquisition assumptions. For investors underwriting office conversions, this suggests that thorough structural due diligence is not a cost center but a core underwriting discipline. It is also a signal that regulatory and public scrutiny of conversion projects in New York will intensify, potentially extending timelines and compressing returns on comparable deals across the city’s pipeline.

Source: The Real Deal

Scroll to Top